date:Dec 26, 2012
nologies and biomedicine, including in the all-important export sector, are jumping into action.
There's an urge to change and do business better, said Daniela Couto, co-founder of Cell2B biomedical startup that raised about 1 million euros earlier this year, mostly from private investors in Portugal, Spain and the United States.
Cell2B is preparing for clinical trials of promising cell therapies aimed at eliminating transplant rejection in humans, after which the founders do not rule out a sh